M

Merck

Makes medicines, vaccines and animal treatments

Key Account Manager

Full-TimeUpdated on 10/15/2026Deadline 10/23/26
No salary listed
Senior
Bachelor's
Rajkot, Gujarat, India+1 moreMore locations: Surat, Gujarat, India
In Person
Sales & Account ManagementField Sales, Account Management

About the job

Requirements
  • A degree in Sciences, Bachelor of Pharmacy, or equivalent is required.
  • At least five years of relevant experience, including a minimum of three years in oncology sales, is required.
  • Proven experience articulating data-driven findings to various audience levels and translating those findings into actionable recommendations is required.
Responsibilities
  • Manage the therapy area efficiently by reaching out to customers, increasing product awareness, answering queries, introducing new products, planning customer coverage, and visiting targeted doctors.
  • Communicate scientific information and product features and benefits to medical doctors, and handle product-related customer queries.
  • Identify and prioritize key and potential medical practitioners and specialists in the territory to generate prescription sales in line with the business plan.
  • Schedule and conduct calls on targeted doctors, chemists, and wholesalers to track sales, book orders, and ensure product availability.
  • Use customer-focused selling techniques, assess customer knowledge, and maintain customer confidence and product knowledge.
  • Maintain approved protocols and promotional materials for sales presentations and product detailing.
  • Contact customers regularly and deliver sales presentations based on their needs.
  • Develop new business within the assigned therapy area.
  • Achieve and exceed sales targets through effective implementation of sales promotion strategies and follow-up initiatives.
  • Use product and therapy knowledge and detailing skills to meet expected productivity levels.
  • Carry out product visibility and related activities for company products or products of other companies as assigned under applicable arrangements.
  • Plan and execute field work and customer coverage according to approved tour programs and required call frequency.
  • Follow up on customer feedback and service requirements.
  • Handle special product campaigns and new product launch campaigns according to company plans.
  • Cover nursing homes, clinics, and hospitals as required.
  • Collect information on annual medicine budgets, purchasing methods, rate contracts, and tendering, and pursue related business opportunities.
  • Assist with receivables collection according to company policy.
  • Nurture strategic relationships with top accounts and maintain in-depth knowledge of the company and its customers.
  • Develop long-term account plans and orchestrate deals aligned with mutually beneficial strategies.
  • Participate in cycle meetings, periodic sales and marketing meetings, and conventions.
  • Conduct group meetings, medical education camps, and speaker programs as needed in the assigned therapy area.
  • Guide team members in designing and executing scientific activities.
  • Participate in training, orienting, and supporting new employees; mentor trainees, probationers, and newly inducted sales professionals.
  • Provide guidance and coaching to territory managers and senior territory managers as needed.
  • Sanction leave for sales professionals according to company procedures.
  • Liaise with stockists and distributors on customer service requirements.
  • Approve claims within prescribed limits for authorized stockists, distributors, and retailers after verification, and provide management with inputs on larger claims.
  • Maintain knowledge of company products, diseases, therapy areas, competitor products, promotional strategies, and objectives, and understand applicable company standard operating procedures and protocols.
  • Follow adverse event reporting guidelines and take prompt compliant action.
  • Maintain quality customer lists and current profiles of assigned key accounts, key influencers, and clinical thought leaders.
  • Execute marketing strategies in accordance with marketing guidelines.
  • Collect market intelligence, conduct market surveys, and participate in special projects.
  • Maintain knowledge of key customers in the territory and therapy area.
  • Lead scientific engagement with key stakeholders and build relationships and rapport with customers.
  • Coordinate with colleagues to arrange speakers, displays, special programs, and continuing medical education activities for customers.
  • Maintain adequate inventory with trade partners and act promptly to prevent product expiry.
  • Submit daily call reports, sales documents, feedback reports, expense reports, and other administrative documents accurately and on time.
  • Demonstrate leader behaviors and undertake other jobs assigned by management.

About the company

Merck develops prescription medicines, vaccines and veterinary treatments for patients, health systems and animal owners worldwide. Its vaccine portfolio includes Gardasil 9, which helps prevent cancers and other diseases caused by several types of human papillomavirus. The company takes potential treatments through laboratory research and clinical trials, then manufactures and sells approved products to drug distributors, hospitals, physicians and governments. Its animal health division sells medicines and vaccines to veterinarians, farmers and pet owners, while selected drug partnerships also earn shared profits or royalties. Founded in 1891, Merck is headquartered in Rahway, New Jersey.

Company Size

10,001+

Company Stage

IPO

Headquarters

Rahway, New Jersey

Founded

1891

Get referred to Merck

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • U.S. employees build retirement benefits: Merck pairs a defined benefit pension with a matching 401(k).
  • Scientists work within a large research network: Merck reports approximately 24,700 employees in R&D.
  • Animal health adds growth: August 2026 results report Q2 sales of $1.8 billion, up 8% year over year.

What critics are saying

  • Job security faces cuts: Merck's active restructuring program eliminates roles and shrinks its global real estate footprint.
  • Keytruda protection narrows: its main U.S. patent expires in 2028, with additional patents expiring in 2029.
  • Revenue is concentrated: August 2026 results show Keytruda products generated $8.4 billion of Merck's $16.6 billion Q2 sales.

What makes Merck unique

  • Merck extends into farm technology: SenseHub continuously monitors livestock for behavioral and physiological changes.
  • Merck publishes open medical knowledge: its Manuals give clinicians and patients free online references.
  • Merck's donation commitment is open-ended: Mectizan supplies for river blindness continue for as long as needed.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

-19%

1 year growth

-20%

2 year growth

-20%
Yahoo Finance
Oct 21st, 2026
Keytruda is half of Merck's $16.6B quarterly sales, so what if growth stalls?

Merck's Keytruda cancer drug family generated $8.4 billion in fiscal Q2 2026, about half of the company's $16.6 billion revenue. Excluding currency, Keytruda sales grew 4%, the same pace as total revenue. Management said on the August 4 call that US Keytruda growth will moderate as the drug reaches peak penetration. A Dutch court has also barred Merck from selling subcutaneous Keytruda in eight European markets, Barron's reported. Newer drugs are growing faster. WINREVAIR sales rose 75% to $588 million, and WELIREG sales rose 67%. Free cash flow of $16.1 billion covered dividends of $8.3 billion about twice. Total debt rose to $53.9 billion from $35.4 billion a year earlier. Merck is expected to report results on October 29.

Ash
Oct 20th, 2026
Ash announces $10M Series A funding to uplevel at-home health testing to close healthcare gaps for millions

Ash secures $10M Series A funding led by Merck GHI Fund. We are scaling at home lab test programs to close care gaps and bring patients into the care cycle.

Yahoo Finance
Oct 19th, 2026
Merck and AbbVie shares jump 39% and 24% in 2026 as dividend picks for a decade

Healthcare stocks are rebounding in 2026, led by Merck and AbbVie. Merck shares have climbed 39% and AbbVie's 24%, against about 12% for the S&P 500. Merck's second-quarter revenue rose 5% to $16.6 billion, beating Wall Street estimates. Keytruda sales hit $8.4 billion, though the drug will likely lose patent exclusivity by 2028. A subcutaneous version, Keytruda Qlex, may help retain market share. Merck's forward dividend yield is 2.3%. AbbVie's revenue grew 10.2% to almost $17 billion, with adjusted earnings per share up 22.9% to $3.65. Skyrizi and Rinvoq sales each rose about 24%, and neither faces US competition until 2033 and 2037 respectively. AbbVie has raised its dividend for 54 straight years, including its time as part of Abbott Laboratories.

WebBizMarket
Oct 19th, 2026
Cancer vaccine manufacturing time could shrink.

Cancer vaccine manufacturing time could shrink. Merck's CEO Rob Davis expressed optimism regarding the manufacturing timeline of the company's cancer vaccine developed in collaboration with Moderna. In a recent interview with CNBC, Davis indicated that efforts are being made to shorten the current six-week production period, which could improve patient access to this innovative treatment. The vaccine is personalized, targeting mutations specific to each patient's tumor, which complicates production but is designed to enhance the immune system's ability to combat cancer. Davis emphasized the complexity of the vaccine manufacturing process but conveyed confidence in the collaboration between Merck and Moderna, stating that they have refined the process to ensure timely delivery to patients. Positive preliminary data from a late-stage trial involving melanoma patients has bolstered this optimism, with ongoing investigations into the vaccine's efficacy against other cancers, including non-small cell lung cancer and bladder cancer. In a related development, Merck has inaugurated a new 120,000-square-foot research facility named Advance at its West Point, Pennsylvania campus. This facility incorporates advanced technology aimed at enhancing research and development processes. The launch comes as Merck anticipates the expiration of patents for its flagship drug, Keytruda, which is essential to its revenue model. To mitigate potential revenue loss, the company plans to bolster its pipeline with both internal research and substantial external acquisitions. Merck is also addressing legal challenges regarding the subcutaneous formulation of Keytruda in Europe, where a recent court ruling has affected its market capabilities. Despite these hurdles, the company remains focused on introducing new therapies, including its recently approved cholesterol-lowering medication, Lipfendra. Why this story matters * This vaccine represents a significant advancement in personalized cancer treatment, potentially improving patient outcomes. Key takeaway * Merck and Moderna are committed to refining the manufacturing process of their personalized cancer vaccine, aiming for broader patient access. Opposing viewpoint * Legal challenges regarding Keytruda's subcutaneous formulation could hinder market penetration and affect future revenues.

Spot On Pennsylvania
Oct 16th, 2026
Merck expands near philadelphia as riverside plant winds down.

Merck expands near philadelphia as riverside plant winds down. RIVERSIDE - While Merck is closing its longtime manufacturing operation in Northumberland County, the pharmaceutical company is preparing a major expansion elsewhere in Pennsylvani... Discover more Get Sports Gear Discover more Read Daily News